{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:58:06Z","timestamp":1785455886163,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-026-10201-3","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:24:55Z","timestamp":1780071895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative multi-omics, machine learning, and experimental validation reveal that TPM1 suppresses M2 macrophage polarization and enhances chemosensitivity in acute myeloid leukemia"],"prefix":"10.1007","volume":"42","author":[{"given":"Yue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baosheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"10201_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21:14.","journal-title":"Mol Cancer"},{"key":"10201_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217772","volume":"625","author":"X Bai","year":"2025","unstructured":"Bai X, Guo YR, Zhao ZM, et al. Macrophage polarization in cancer and beyond: from inflammatory signaling pathways to potential therapeutic strategies. Cancer Lett. 2025;625:217772.","journal-title":"Cancer Lett"},{"key":"10201_CR3","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","volume":"401","author":"CD DiNardo","year":"2023","unstructured":"DiNardo CD, Erba HP, Freeman SD, Wei AH. Acute myeloid leukaemia. Lancet. 2023;401:2073\u201386.","journal-title":"Lancet"},{"key":"10201_CR4","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/jleuko\/qiae106","volume":"116","author":"Z Fang","year":"2024","unstructured":"Fang Z, Ding H, Han J, et al. Functions of N6-methyladenosine (m6A) RNA modifications in acute myeloid leukemia. J Leukoc Biol. 2024;116:662\u201371.","journal-title":"J Leukoc Biol"},{"key":"10201_CR5","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/ijc.33908","volume":"150","author":"S Ganesan","year":"2022","unstructured":"Ganesan S, Mathews V, Vyas N. Microenvironment and drug resistance in acute myeloid leukemia: do we know enough? Int J Cancer. 2022;150:1401\u201311.","journal-title":"Int J Cancer"},{"key":"10201_CR6","first-page":"1025","volume":"109","author":"L Guarnera","year":"2024","unstructured":"Guarnera L, Visconte V. Using machine learning to unravel the intricacy of acute myeloid leukemia. Haematologica. 2024;109:1025\u20136.","journal-title":"Haematologica"},{"key":"10201_CR7","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/cac2.70004","volume":"45","author":"B He","year":"2025","unstructured":"He B, Hu Y, Wu Y, et al. Helicobacter pylori CagA elevates FTO to induce gastric cancer progression via a \u201chit-and-run\u201d paradigm. Cancer Commun (Lond). 2025;45:608\u201331.","journal-title":"Cancer Commun (Lond)"},{"key":"10201_CR8","doi-asserted-by":"publisher","unstructured":"Hu L, Fang L, Zhang ZP, Yan ZL. TPM1 is a novel predictive biomarker for gastric cancer diagnosis and prognosis. Clin Lab. 2020;66. https:\/\/doi.org\/10.7754\/Clin.Lab.2019.190235.","DOI":"10.7754\/Clin.Lab.2019.190235"},{"key":"10201_CR9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","volume":"35","author":"Y Huang","year":"2019","unstructured":"Huang Y, Su R, Sheng Y, et al. Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia. Cancer Cell. 2019;35:677-691.e610.","journal-title":"Cancer Cell"},{"key":"10201_CR10","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1038\/s41467-025-58966-1","volume":"16","author":"F Huang","year":"2025","unstructured":"Huang F, Wang Y, Zhang X, et al. m(6)A\/IGF2BP3-driven serine biosynthesis fuels AML stemness and metabolic vulnerability. Nat Commun. 2025;16:4214.","journal-title":"Nat Commun"},{"key":"10201_CR11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","volume":"31","author":"Z Li","year":"2017","unstructured":"Li Z, Weng H, Su R, et al. FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-methyladenosine RNA demethylase. Cancer Cell. 2017;31:127\u201341.","journal-title":"Cancer Cell"},{"key":"10201_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-025-10073-z","volume":"41","author":"Z Li","year":"2025","unstructured":"Li Z, Ma J, Guan H, et al. FTO-mediated the destabilization of RASGRF1 mRNA impedes thyroid cancer progression and suppresses macrophage M2 polarization. Cell Biol Toxicol. 2025;41:123.","journal-title":"Cell Biol Toxicol"},{"key":"10201_CR13","doi-asserted-by":"publisher","first-page":"102452","DOI":"10.1016\/j.redox.2022.102452","volume":"56","author":"J Liu","year":"2022","unstructured":"Liu J, Wei Y, Jia W, et al. Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS\/p38 MAPK\/DGAT1 pathway and inhibiting M2 macrophage polarization. Redox Biol. 2022;56:102452.","journal-title":"Redox Biol"},{"key":"10201_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1176637","volume":"13","author":"X Liu","year":"2023","unstructured":"Liu X, Li X, Kuang Q, Luo H. Screening of immunotherapy-related genes in bladder cancer based on GEO datasets. Front Oncol. 2023;13:1176637.","journal-title":"Front Oncol"},{"key":"10201_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s10616-025-00800-z","volume":"77","author":"B Liu","year":"2025","unstructured":"Liu B, Liu Q, Liu Y, Xiong Z, Hu Y. ELF3 regulates epithelial-mesenchymal transition through TPM1 and promotes the development of endometrial cancer. Cytotechnology. 2025a;77:134.","journal-title":"Cytotechnology"},{"key":"10201_CR16","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.62347\/RGDP9493","volume":"15","author":"B Liu","year":"2025","unstructured":"Liu B, Yan Y, Guo J. FTO-mediated m6A modification of QPCT promotes tumorigenesis in lung adenocarcinoma by inducing macrophage chemotaxis and M2 polarization. Am J Cancer Res. 2025b;15:1036\u201350.","journal-title":"Am J Cancer Res"},{"key":"10201_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.692800","volume":"9","author":"KE Miari","year":"2021","unstructured":"Miari KE, Guzman ML, Wheadon H, Williams MTS. Macrophages in acute myeloid leukaemia: significant players in therapy resistance and patient outcomes. Front Cell Dev Biol. 2021;9:692800.","journal-title":"Front Cell Dev Biol"},{"key":"10201_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/0115701646326324240924163955","volume":"21","author":"S Misir","year":"2024","unstructured":"Misir S, Yaman SO, Aykac O, et al. Determination of FGFR1 functions in cytarabine treatment of acute myeloid leukemia through bioinformatics analysis. Curr Proteomics. 2024;21:437\u201348.","journal-title":"Curr Proteomics"},{"key":"10201_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/1471-2407-9-282","volume":"9","author":"V Mlakar","year":"2009","unstructured":"Mlakar V, Berginc G, Volavsek M, et al. Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer. BMC Cancer. 2009;9:282.","journal-title":"BMC Cancer"},{"key":"10201_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2023.115532","volume":"266","author":"Q Ning","year":"2023","unstructured":"Ning Q, Jian T, Cui S, et al. Tim-3 facilitates immune escape in benzene-induced acute myeloid leukemia mouse model by promoting macrophage M2 polarization. Ecotoxicol Environ Saf. 2023;266:115532.","journal-title":"Ecotoxicol Environ Saf"},{"key":"10201_CR21","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1158\/1055-9965.EPI-25-1058","volume":"34","author":"Y Park","year":"2025","unstructured":"Park Y, Cn K, Willekens J, et al. Treatment-related changes in cerebrospinal fluid markers of oxidative stress and neurodegeneration during therapy for childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev. 2025;34:2015\u201324.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10201_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02841-8","volume":"42","author":"E Peroni","year":"2023","unstructured":"Peroni E, Randi ML, Rosato A, Cagnin S. Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment. J Exp Clin Cancer Res. 2023;42:259.","journal-title":"J Exp Clin Cancer Res"},{"key":"10201_CR23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13046-024-03032-9","volume":"43","author":"Y Qiao","year":"2024","unstructured":"Qiao Y, Su M, Zhao H, et al. Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11\/GPX4 expression. J Exp Clin Cancer Res. 2024;43:108.","journal-title":"J Exp Clin Cancer Res"},{"key":"10201_CR24","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/hep.32184","volume":"75","author":"J Rao","year":"2022","unstructured":"Rao J, Qiu J, Ni M, et al. Macrophage nuclear factor erythroid 2-related factor 2 deficiency promotes innate immune activation by tissue inhibitor of metalloproteinase 3-mediated RhoA\/ROCK pathway in the ischemic liver. Hepatology. 2022;75:1429\u201345.","journal-title":"Hepatology"},{"key":"10201_CR25","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1182\/blood.2024024245","volume":"145","author":"DA Sallman","year":"2025","unstructured":"Sallman DA, Stahl M. TP53-mutated acute myeloid leukemia: how can we improve outcomes? Blood. 2025;145:2828\u201333.","journal-title":"Blood"},{"key":"10201_CR26","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3324\/haematol.2022.280803","volume":"108","author":"RF Schlenk","year":"2023","unstructured":"Schlenk RF. Acute myeloid leukemia: introduction to a series highlighting progress and ongoing challenges. Haematologica. 2023;108:306\u20137.","journal-title":"Haematologica"},{"key":"10201_CR27","first-page":"437","volume":"21","author":"M Sema","year":"2024","unstructured":"Sema M, Serap Ozer Y, Okan A, et al. Determination of FGFR1 functions in cytarabine treatment of acute myeloid leukemia through bioinformatics analysis. Curr Proteomics. 2024;21:437\u201348.","journal-title":"Curr Proteomics"},{"key":"10201_CR28","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.2174\/1570180820666230519140242","volume":"21","author":"W Shi-Han","year":"2024","unstructured":"Shi-Han W, Yi-Yuan M, Li-Jin Y, et al. Scaffold-hopping of linifanib to design 6-phenylisoxazolo[3,4-b]pyridin-3-amine derivatives as FLT3 inhibitors for treating acute myeloid leukemia. Lett Drug des Discov. 2024;21:1833\u201346.","journal-title":"Lett Drug des Discov"},{"key":"10201_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18102156","author":"WT Soh","year":"2017","unstructured":"Soh WT, Briza P, Dall E, et al. Two distinct conformations in Bet v 2 determine its proteolytic resistance to Cathepsin S. Int J Mol Sci. 2017;18:2156. https:\/\/doi.org\/10.3390\/ijms18102156.","journal-title":"Int J Mol Sci"},{"key":"10201_CR30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3324\/haematol.2022.280800","volume":"108","author":"P Stelmach","year":"2023","unstructured":"Stelmach P, Trumpp A. Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica. 2023;108:353\u201366.","journal-title":"Haematologica"},{"key":"10201_CR31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41586-025-09202-9","volume":"645","author":"H Tang","year":"2025","unstructured":"Tang H, Wei Z, Zheng B, et al. Rescuing dendritic cell interstitial motility sustains antitumour immunity. Nature. 2025;645:244\u201353.","journal-title":"Nature"},{"key":"10201_CR32","doi-asserted-by":"publisher","first-page":"e415","DOI":"10.1016\/S2352-3026(22)00106-5","volume":"9","author":"H Wang","year":"2022","unstructured":"Wang H, Mao L, Yang M, et al. Venetoclax plus 3\u2009+\u20097 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial. Lancet Haematol. 2022;9:e415\u201324.","journal-title":"Lancet Haematol"},{"key":"10201_CR33","first-page":"0252","volume":"6","author":"H Wang","year":"2023","unstructured":"Wang H, Liu J, Zhu X, et al. AZGP1P2\/UBA1\/RBM15 cascade mediates the fate determinations of prostate cancer stem cells and promotes therapeutic effect of docetaxel in castration-resistant prostate cancer via TPM1 m6A modification. Res (Wash D c). 2023;6:0252.","journal-title":"Res (Wash D c)"},{"key":"10201_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jare.2024.12.026","volume":"76","author":"S Wang","year":"2025","unstructured":"Wang S, Zhang X, Chen Q, et al. FTO activates PD-L1 promotes immunosuppression in breast cancer via the m6A\/YTHDF3\/PDK1 axis under hypoxic conditions. J Adv Res. 2025;76:191\u2013206.","journal-title":"J Adv Res"},{"key":"10201_CR35","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1111\/jth.13129","volume":"13","author":"CM Williams","year":"2015","unstructured":"Williams CM, Harper MT, Goggs R, et al. Leukemia-associated Rho guanine-nucleotide exchange factor is not critical for RhoA regulation, yet is important for platelet activation and thrombosis in mice. J Thromb Haemost. 2015;13:2102\u20137.","journal-title":"J Thromb Haemost"},{"key":"10201_CR36","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41418-024-01267-9","volume":"31","author":"T Xu","year":"2024","unstructured":"Xu T, Verhagen MP, Teeuwssen M, et al. Tropomyosin1 isoforms underlie epithelial to mesenchymal plasticity, metastatic dissemination, and resistance to chemotherapy in high-grade serous ovarian cancer. Cell Death Differ. 2024;31:360\u201377.","journal-title":"Cell Death Differ"},{"key":"10201_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-02867-8","volume":"16","author":"F Xu","year":"2025","unstructured":"Xu F, Lv J, Qin S, Liu L, Ren Y. Amplified TPM1 suppresses non-small cell lung cancer cells proliferation and metastasis. Discov Oncol. 2025;16:1098.","journal-title":"Discov Oncol"},{"key":"10201_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.curpro.2025.100028","volume":"22","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhang J. Comprehensive omics profiling in acute myeloid leukemia: from molecular landscape to clinical translation. Curr Proteomics. 2025;22:100028.","journal-title":"Curr Proteomics"},{"key":"10201_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05023-0","volume":"13","author":"F Zhang","year":"2022","unstructured":"Zhang F, Sun J, Tang X, et al. Stabilization of SAMHD1 by NONO is crucial for Ara-C resistance in AML. Cell Death Dis. 2022;13:590.","journal-title":"Cell Death Dis"},{"key":"10201_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01505-y","volume":"9","author":"ZW Zhang","year":"2023","unstructured":"Zhang ZW, Zhao XS, Guo H, Huang XJ. The role of m(6)A demethylase FTO in chemotherapy resistance mediating acute myeloid leukemia relapse. Cell Death Discov. 2023;9:225.","journal-title":"Cell Death Discov"},{"key":"10201_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40364-024-00600-1","volume":"12","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Huang J, Zhang Z, et al. Application of omics in the diagnosis, prognosis, and treatment of acute myeloid leukemia. Biomark Res. 2024;12:60.","journal-title":"Biomark Res"},{"key":"10201_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03282-1","volume":"44","author":"S Zhang","year":"2025","unstructured":"Zhang S, Zhang N, Wan T, et al. Oncometabolite D-2HG drives tumor metastasis and protumoral macrophage polarization by targeting FTO\/m(6)A\/ANGPTL4\/integrin axis in triple-negative breast cancer. J Exp Clin Cancer Res. 2025;44:41.","journal-title":"J Exp Clin Cancer Res"},{"key":"10201_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40164-024-00480-z","volume":"13","author":"W Zhou","year":"2024","unstructured":"Zhou W, Li S, Wang H, et al. A novel AML1-ETO\/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabilizing IGFBP2 in t(8;21) acute myeloid leukemia. Exp Hematol Oncol. 2024;13:9.","journal-title":"Exp Hematol Oncol"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-026-10201-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-026-10201-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-026-10201-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:04:30Z","timestamp":1785452670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-026-10201-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10201"],"URL":"https:\/\/doi.org\/10.1007\/s10565-026-10201-3","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study was approved by the ethical review committee of Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine with approval No.20250222. Written informed consent was obtained from all enrolled patients.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was carried out in strict accordance with the relevant regulations and requirements of the Declaration of Helsinki. Written informed consents were obtained from all participants and this study was permitted by the Ethics Committee of Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine.","order":2,"name":"Ethics","label":"Human study","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The procedures performed on all animals complied with the standards formulated by the Experimental Animal Ethics Committee of Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine and obtained the approval of the said committee.","order":3,"name":"Ethics","label":"Animal study","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":5,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"98"}}